Collegium Pharmaceutical, Inc. Payments for Restructuring
Collegium Pharmaceutical, Inc. (COLL) reported Payments for Restructuring of $3.24 million for the 6-month period ending 2022-06-30, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2024-02-22
- Collegium Pharmaceutical, Inc. payments for restructuring for the quarter ending 2021-12-31 was $1.33M.
| Period end | Payments for Restructuring 1 month | Payments for Restructuring 3 month | Payments for Restructuring 6 month |
|---|---|---|---|
| 2022-06-30 | $3.24M 10-K · filed 2024-02-22 | ||
| 2022-01-31 | $2.98M 10-K · filed 2022-02-24 | ||
| 2021-12-31 | $1.33M 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |